Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Peter Greenleaf

Affiliations

  • Director at Antares Pharma Inc. (ATRS), 2019-06-14
  • Director at Cerecor Inc. (CERC), 2019-05-29
  • Director at Eyegate Pharmaceuticals Inc (EYEG), 2019-02-05
  • Director at Biodelivery Sciences International Inc (BDSI), 2018-08-16
  • Chief Executive Officer at Sucampo Pharmaceuticals Inc. (SCMP), 2018-02-13
  • Director at Mast Therapeutics Inc. (MSTX), 2017-01-23
  • Director at Mirna Therapeutics Inc. (MIRN), 2016-09-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
CERC $3.98 12,500 Officer, Director 412,500 2018-05-18 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
SCMP $16.75 82,459 Officer 2,513 2016-11-29 Filing
SCMP $16.91 117,541 Officer 2,513 2016-11-28 Filing